ES2044887T3 - Metodo para la preparacion de factor de crecimiento de tipo insulina i. - Google Patents
Metodo para la preparacion de factor de crecimiento de tipo insulina i.Info
- Publication number
- ES2044887T3 ES2044887T3 ES87114733T ES87114733T ES2044887T3 ES 2044887 T3 ES2044887 T3 ES 2044887T3 ES 87114733 T ES87114733 T ES 87114733T ES 87114733 T ES87114733 T ES 87114733T ES 2044887 T3 ES2044887 T3 ES 2044887T3
- Authority
- ES
- Spain
- Prior art keywords
- igf
- preparation
- growth factor
- type growth
- met
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24070286 | 1986-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2044887T3 true ES2044887T3 (es) | 1994-01-16 |
Family
ID=17063431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES87114733T Expired - Lifetime ES2044887T3 (es) | 1986-10-09 | 1987-10-08 | Metodo para la preparacion de factor de crecimiento de tipo insulina i. |
Country Status (5)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0227993A (ja) * | 1988-07-15 | 1990-01-30 | Nippon Shinyaku Co Ltd | ｈＥＧＦの製法 |
| KR920003787B1 (ko) * | 1990-03-05 | 1992-05-14 | 한국과학기술 연구원 | 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법 |
| JP3377524B2 (ja) * | 1990-05-30 | 2003-02-17 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | 創傷治癒 |
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| US5712249A (en) * | 1994-09-08 | 1998-01-27 | Ciba-Geigy Corporation | Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| JPH10504971A (ja) * | 1994-09-08 | 1998-05-19 | カイロン コーポレイション | インスリン様増殖因子の改善された生産方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK108685A (da) * | 1984-03-19 | 1985-09-20 | Fujisawa Pharmaceutical Co | Vaekstfaktor i |
| DK151585D0 (da) * | 1985-04-03 | 1985-04-03 | Nordisk Gentofte | Dna-sekvens |
| DE3686365T3 (de) * | 1985-06-20 | 2000-07-27 | Fujisawa Pharmaceutical Co., Ltd. | Herstellungsverfahren für humanes atriales natriuretisches Polypeptid. |
-
1987
- 1987-10-08 EP EP87114733A patent/EP0264074B1/en not_active Expired - Lifetime
- 1987-10-08 DE DE8787114733T patent/DE3783305T2/de not_active Expired - Fee Related
- 1987-10-08 AT AT87114733T patent/ATE84065T1/de not_active IP Right Cessation
- 1987-10-08 ES ES87114733T patent/ES2044887T3/es not_active Expired - Lifetime
-
1993
- 1993-03-30 GR GR920403173T patent/GR3007491T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE84065T1 (de) | 1993-01-15 |
| GR3007491T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-07-30 |
| DE3783305D1 (de) | 1993-02-11 |
| EP0264074B1 (en) | 1992-12-30 |
| EP0264074A3 (en) | 1989-10-25 |
| EP0264074A2 (en) | 1988-04-20 |
| DE3783305T2 (de) | 1993-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG60107B2 (bg) | Метод за получаване на еукариотен полипептид | |
| ATE107958T1 (de) | Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins. | |
| EP0156355A3 (en) | Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria | |
| FI102075B1 (fi) | Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit | |
| BG60053B2 (bg) | Метод за повишаване способността за получаване на антибиотик | |
| FI104261B1 (fi) | Menetelmä yhdistelmä ihmisen erytropoietiinin tuottamiseksi | |
| IL83192A (en) | Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies | |
| BG42527A3 (en) | Method for preparing human immunic interferon | |
| EP0260148A3 (en) | Improved recombinant expression method, vector and transformed cells | |
| DE69229572D1 (de) | Gliazellen-aktivierender Faktor und dessen Herstellung | |
| ES2044887T3 (es) | Metodo para la preparacion de factor de crecimiento de tipo insulina i. | |
| FI895935A0 (fi) | Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi | |
| YU179489A (en) | Process for preparing new derivatives of human/cattle basis fibroblast growth factor | |
| GB2196636A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| AU605155B2 (en) | A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof | |
| AU7151687A (en) | Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same | |
| DK502786A (da) | Fremgangsmaade til fremstilling af en vaekstfaktor | |
| DK181790D0 (da) | Fermenteringsmedier og fremgangsmaader til regulering af norleucinindholdet i polypeptider | |
| EP0473080A3 (en) | Chondromodulin-i protein | |
| DK171489A (da) | Peptidderivater | |
| DK197091A (da) | Fremgangsmaade til fremstilling af proteiner med fviii aktivitet og/eller fviii derivater | |
| ZA875267B (en) | Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies | |
| CA2058785A1 (en) | Method of producing proteins with fviii activity and/or fviii derivatives | |
| IE871932L (en) | Method for the preparation of proteins with factor viii¹activity by microbial host cells, expression vectors, host¹cells, antibodies | |
| SU1380209A1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 264074 Country of ref document: ES |